Novel HCV Infection Combo Tx Gets FDA OK

The Food and Drug Administration (FDA) has approved Viekira Pak (ombitasvir, paritaprevir, ritonavir with dasabuvir tablets; AbbVie) for the treatment of patients with chronic hepatitis C virus (HCV) genotype 1 infection, including cirrhosis.

Wearables Predicted to Save 1.3 Million Lives By 2020

Smart wearable devices could help to save as many as 1.3 million lives by the year 2020, according to a report from Soreon Research.

Tempol, Antibiotics Promising as Nonalcoholic Fatty Liver Disease Tx

Inhibiting an intestinal nuclear receptor using tempol and antibiotics appears to be a promising treatment for nonalcoholic fatty liver disease (NAFLD).

Many Patients Don't Trust Doctors, Yet Satisfied with Care

A survey in the New England Journal of Medicine has found that the United States ranks third out of 29 countries in patient satisfaction from treatment received at their last visit with a doctor, but 24th in patient trust of doctors overall.

Can IV Acetaminophen Reduce Opioid Use for Postoperative Pain?

Multimodal analgesia for postoperative pain may help to reduce opioid use and decrease opoid-associated adverse effects, but is there an opioid-sparing effect with use of intravenous (IV) acetaminophen?

First-in-Class Drug for Advanced Ovarian Cancer Approved

The Food and Drug Administration (FDA) has granted accelerated approval for Lynparza (olaparib; AstraZeneca) for the treatment of advanced ovarian cancer associated with defective BRCA genes.

Too Late to Get the Influenza Vaccine? Not So, Says CDC

The flu is starting to tighten its grip on much of the United States, but vaccination remains the most effective means to prevent influenza and its complications.

Report: States Ill-Prepared for Ebola, Other Infectious Outbreaks

According to a new report, half of U.S. states are poorly prepared to prevent, detect, and respond to infectious disease outbreaks.

Predict Stroke Risk by Standing on One Leg? Yes, Says Study

Difficulty standing on one leg may indicate that or microbleeds have already occurred, which means the risk for more serious strokes is high, according to new research.

Vision Loss Risk Cut in Half with Prostaglandin Analogue Eye Drops for Glaucoma

Prostaglandin analogue eye drops significantly reduce the risk of vision loss in patients with glaucoma, reports a new study.